Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
- 165 views
Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and RecoverySummary'Global Drug Manufacturing Industry Outlook to 2010: Marketing & Sales ...
Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and RecoverySummary'Global Drug Manufacturing Industry Outlook to 2010: Marketing & Sales Strategies and the Impact of Recession and Recovery' is a new report published by Global Markets Direct in association with ICD Research that analyzes how drugs manufacturer's and equipment, materials and service supplier's media spend, marketing and sales strategies & practices and business are being affected by the recession. In an uncertain economic climate this report gives you access to the media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges and sales tactics of leading buyers and suppliers. The report also identifies drug manufacturers and suppliers future growth, M&A and investment expectations. The research is based on an extensive survey of senior and C-level industry executives from our market leading panels. Scope- The opinions and forward looking statements of over 550 industry executives have been captured in our in-depth survey, of which 65% represent Directors, C-levels & Departmental Heads - This report covers data and analysis on media channel spend, marketing and sales practices and industry developments by drugs manufacturing companies and their suppliers- The report examines current practices and provides future expectations over the next 12-24 months- The research is based on primary survey research conducted by Global Markets Direct in association with ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations- Key topics covered include media spend activity, marketing and sales behaviors & strategies by drugs manufacturing companies and their suppliers and how these have been affected by the recession, as well as threats & opportunities, investment outlook and business confidence among both buyers and suppliers.- In the report buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats- The report provides qualitative analysis of key industry opportunities and threats and contains full survey results- The geographical scope of the research is global ' drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle EastHighlights- 50% of industry players are looking to increase their marketing expenditure over the next 12 months, with only 36% looking to decrease it- 32% of industry players are adapting product portfolios or positioning to meet clients cost pressures- 59% of companies believe that the demonstration of confidence to their customers from increased marketing activity in the current business climate can give their company an edgeReasons to buy- Benchmark your sales and marketing plans with industry competitors to effectively determine strategy- Identify the specific marketing approaches your competitors are using to win business during the recessionary climate- Better promote your business by aligning your capabilities and business practices with your customer's changing needs during these times of market uncertainty- Secure stronger customer relationships by understanding the leading business concerns and changing strategies of buyers in the pharmaceutical industry- Effectively plan your business strategies- Predict how the industry will grow, consolidate and where it will stagnate- Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers in the industry
- Total Views
- Views on SlideShare
- Embed Views